Status:
COMPLETED
Prospective Randomized Trial Comparing Corifollitropin-alfa Late Start vs. Corifollitropin-alfa Standard Start in Expected Poor, Normal and High-responders Undergoing IVF
Lead Sponsor:
University of Turin, Italy
Conditions:
Fertility Disorders
Eligibility:
FEMALE
18-43 years
Phase:
NA
Brief Summary
To compare the number of retrieved oocytes in the late start CF-alfa (day 4) versus standard CF-alfa protocols (day 2) in patients undergoing IVF. The primary analysis will be also performed in specif...
Detailed Description
The investigators hypothesize that: 1. CF-alfa late start (day 4) will show comparable efficacy in terms of number of retrieved oocytes versus standard CF-alfa (day 2) protocol. In certain groups of ...
Eligibility Criteria
Inclusion
- aged 18- 43 years
- Male or tubal infertility with indication for IVF treatment
- No PCOS
- No previous IVF treatments in the past two months
- No history of previous Ovarian Hyperstimulation Syndrome (OHSS)
- No previous IVF cycle with more than 30 growing follicles ≥ 11 mm
- Antral Follicle Count (AFC) \<20
- No ovarian cyst nor malignant ovarian tumour, breast, uterus or central nervous cancer
Exclusion
- AMH \< 0.2 ng/ml
- Età \> 43 anni
Key Trial Info
Start Date :
April 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT03816670
Start Date
April 1 2017
End Date
December 31 2018
Last Update
January 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Physiopathology of Reproduction and IVF Unit, S. Anna Hospital
Torino, Italy, 10126